Content Type: Research Publications

The US Biosimilar Market: Stunted Growth and Possible Reforms

March 15, 2026

Patent Term Restoration for Top-Selling Drugs in the United States

March 15, 2026

Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration’s Adverse Event Reporting System

March 15, 2026

Completion Rate and Reporting of Mandatory Pediatric Postmarketing Studies Under the US Pediatric Research Equity Act

March 15, 2026

Metrics for Quantifying Antibiotic Use in the Hospital Setting: Results From a Systematic Review and International Multidisciplinary Consensus Procedure

March 15, 2026

Generic Versions of Narrow Therapeutic Index Drugs: A National Survey of Pharmacists’ Substitution Beliefs and Practices

March 15, 2026

Efficacy, Safety, and Regulatory Approval of Food and Drug Administration-Designated Breakthrough and Nonbreakthrough Cancer Medicines

March 15, 2026

A Comparison of Response Patterns for Progression-Free Survival and Overall Survival Following Treatment for Cancer with PD-1 Inhibitors: A Meta-Analysis of Correlation and Differences in Effect Sizes

March 15, 2026

Use of Health Care Databases to Support Supplemental Indications of Approved Medications

March 15, 2026

Implementing a Public Health Perspective in FDA Drug Regulation

March 15, 2026

Social Media Impact of the Food and Drug Administration’s Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis

March 15, 2026

Medicare Spending on Brand-Name Combination Medications vs Their Generic Constituents

March 15, 2026